NEW YORK, Oct 5 – Proteomics company GeneFormatics said Thursday it raised $15 million in a series B round of financing.

Perseus-Soros BioPharmaceutical Fund led the round. Merrill Lynch Ventures, OrbiMed Advisors, GeneChem Management and previous investors, Burrill & Company, Inglewood Ventures, and Moss Forest Venture also participated in the financing round.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.